Live Breaking News & Updates on Greg zante

Stay informed with the latest breaking news from Greg zante on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Greg zante and stay connected to the pulse of your community

Viking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from HC Wainwright

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They currently have a $90.00 target price on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 6.26% from the stock’s previous close. […]

Switzerland , Swiss , William-blair , Greg-zante , Maxim-group , Dimensional-fund-advisors , Blackrock-inc , Securities-exchange-commission , York-mellon-corp , Therapeutics-inc , Jpmorgan-chase-co , Swiss-national-bank

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $138.00

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) had its target price raised by equities research analysts at Oppenheimer from $116.00 to $138.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price target would indicate a potential upside of 65.27% from the stock’s […]

New-york , United-states , Raymond-james , William-blair , Stifel-nicolaus , Greg-zante , Therapeutics-inc , Retirement-group , Great-west-life-assurance-co , Maxim-group , Sei-investments-co , Therapeutics-company-profile

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $138.00

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) had its price objective raised by research analysts at Oppenheimer from $116.00 to $138.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 65.27% from the company’s previous […]

Raymond-james , Sarah-kathryn-rouan , Greg-zante , Stifel-nicolaus , Maxim-group , Blackrock-inc , Jefferies-financial-group , Therapeutics-inc , Vanguard-group-inc , Viking-therapeutics , Get-free-report , Financial-group

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $138.00

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) had its target price raised by equities research analysts at Oppenheimer from $116.00 to $138.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price target would indicate a potential upside of 65.27% from the stock’s […]

New-york , United-states , William-blair , Greg-zante , Stifel-nicolaus , Raymond-james , Retirement-group , Great-west-life-assurance-co , Therapeutics-inc , Sei-investments-co , York-state-common-retirement-fund , Therapeutics-company-profile

Salem Investment Counselors Inc. Takes $1.24 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)

Salem Investment Counselors Inc. purchased a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 66,530 shares of the biotechnology company’s stock, valued at approximately $1,238,000. Salem Investment Counselors Inc. owned approximately […]

Stifel-nicolaus , Sarah-kathryn-rouan , Greg-zante , Maxim-group , Blackrock-inc , Therapeutics-inc , Salem-investment-counselors-inc , Marshall-wace , Nasdaq , Securities-exchange-commission , Salem-investment-counselors , Viking-therapeutics

Salem Investment Counselors Inc. Takes $1.24 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)

Salem Investment Counselors Inc. Takes $1.24 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Greg-zante , Sarah-kathryn-rouan , Securities-exchange-commission , Nasdaq , Marshall-wace , Therapeutics-inc , Maxim-group , Blackrock-inc , Salem-investment-counselors-inc , Salem-investment-counselors , Viking-therapeutics

Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.6%

Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.6%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Swiss , Sarah-kathryn-rouan , Stifel-nicolaus , Greg-zante , Raymond-james , Swiss-national-bank , Jpmorgan-chase-co , York-mellon-corp , Maxim-group , Nasdaq , Dimensional-fund-advisors

Deerfield Management Company L.P. Series C Has $14.16 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)

Deerfield Management Company L.P. Series C raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 13.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,279,000 shares of the biotechnology company’s stock after buying an additional 154,000 shares during the […]

Greg-zante , William-blair , Securities-exchange-commission , Life-insurance-co , Maxim-group , Allspring-global-investments-holdings , Therapeutics-inc , Deerfield-management-companylp-series , Retirement-group , Nasdaq , Exchange-commission , Great-west-life-assurance-co

Deerfield Management Company L.P. Series C Acquires 154,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)

Deerfield Management Company L.P. Series C lifted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 13.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,279,000 shares of the biotechnology company’s stock after purchasing an additional 154,000 shares during the quarter. Deerfield […]

Raymond-james , Greg-zante , William-blair , Stifel-nicolaus , Securities-exchange-commission , Allspring-global-investments-holdings , Life-insurance-co , Retirement-group , Deerfield-management-companylp-series , Therapeutics-inc , Great-west-life-assurance-co , Nasdaq

Aigen Investment Management LP Invests $148,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)

Aigen Investment Management LP acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 13,396 shares of the biotechnology company’s stock, valued at approximately $148,000. Several other institutional investors and […]

Stifel-nicolaus , William-blair , Greg-zante , Sarah-kathryn-rouan , Securities-exchange-commission , Balyasny-asset-management , Vanguard-group-inc , Nasdaq , Maxim-group , Therapeutics-inc , Blackrock-inc , Aigen-investment-management